Bausch Health Companies vs Haleon
Haleon is the larger business, with $14.55bn of revenue in fiscal 2025 against $10.27bn for Bausch Health Companies (1.4 times as much). Bausch Health Companies grew faster (6.7% against 1.3%). Haleon kept more of each dollar of sales as profit: a net margin of 15.1% against 1.5%.
| Latest fiscal year | Bausch Health CompaniesBHC, 2025 | HaleonHLN, 2025 |
|---|---|---|
| Revenue | $10.27bn | $14.55bn |
| Revenue growth | 6.7% | 1.3% |
| Net income | $157m | $2.20bn |
| Operating margin | 17.7% | 21.9% |
| Net margin | 1.5% | 15.1% |
| Return on equity | — | 10.4% |
| Free cash flow | $1.00bn | $3.05bn |
| Cash | $1.31bn | $1.78bn |
| Total debt | $20.82bn | $11.58bn |
| Debt to equity | — | 52.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 20,300 | — |
| Market value | $3.01bn | $39.59bn |
| Price vs our value range | Below our value range | Above our value range |
| Moat score | 35 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |